Mixed Results For EMA's Early Pediatric Advice Pilot
This article was originally published in SRA
Executive Summary
The European Medicines Agency has accepted only four of the 15 applications received so far under its early interaction pilot, which offers free scientific advice to drug companies in an effort to stimulate pediatric development1,2.